Results 121 to 130 of about 1,685 (168)
Crystal structures of two isomers of 1-(naphthalen-1-yl)ethanol. [PDF]
Golz C.
europepmc +1 more source
The detection of toxins in baby food using artificial intelligence. ABSTRACT Infant foods and baby formulas are becoming increasingly popular across the globe owing to their ease of consumption and nutritional value specific to infants. Impurities may find their way into the food chain at any point from the acquisition of raw materials to final ...
Poornima Singh +3 more
wiley +1 more source
Risk Assessment of Dibutyl Phthalate (DBP) and Bis(2-Ethylhexyl) Phthalate (DEHP) in Hot Pot Bases with a Hybrid Modeling Approach. [PDF]
Bian X +10 more
europepmc +1 more source
ABSTRACT Background Nutraceutical supplementation targeting mitochondrial function has been proposed as a beneficial therapeutic strategy to improve physical and mental health in psychiatric patients. Aims To summarise the results of studies evaluating nutraceutical supplementation targeting mitochondrial function in patients with psychiatric disorders.
Juan Tortajada +9 more
wiley +1 more source
Toxicity of the Antiretrovirals Lamivudine, Dolutegravir, and Tenofovir on the Microalga <i>Chlorella vulgaris</i>. [PDF]
Souza-Silva G +8 more
europepmc +1 more source
Isometries of Spacetimes Without Observer Horizons. [PDF]
García-Heveling L, Zeghib A.
europepmc +1 more source
Human Gut Phageome Analysis Uncovers Thousands of Highly Modular Endolysins
Analysis of 9141 human gut metagenomes identified 15,267 phage genomes and 3794 highly modular endolysins. The recovered endolysins showed remarkable catalytic and cell wall–binding domain diversity, highlighting the gut phageome as a rich source of novel enzybiotics with therapeutic potential against multidrug‐resistant bacteria.
Raphael Kabir Niloy +6 more
wiley +1 more source
New polymorph of 2,6-di-methyl-phenol. [PDF]
Slaats T, Lutz M.
europepmc +1 more source
Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps
Abstract Background Effective drug treatment of motor and non‐motor symptoms in Parkinson's disease (PD) often requires the administration of several anti‐Parkinson drugs in complex treatment regimens. The successful autonomous application of drugs places high demands on therapy adherence, which in turn relies on sufficient medication knowledge ...
Stephan Greten +9 more
wiley +1 more source
Effectiveness of Non-Face-to-Face Behavioral Activation Treatment for Negative Symptoms of Schizophrenia: A Prospective, Non-Randomized Study. [PDF]
Kim WH, Kim HS, Lee TJ, Koo HJ.
europepmc +1 more source

